期刊文献+

利用诱导因子Oct4、Sox2和SV40T的mRNA介导体细胞重编程研究 被引量:4

Cellular Reprogramming by in vitro Transcribed mRNA Cocktail of Oct4,Sox2 and SV40 T-antigen
下载PDF
导出
摘要 为利用特定诱导因子Oct4、Sox2和SV40T的体外转录mRNA实现安全的成纤维细胞重编程,本研究成功构建了特定诱导因子Oct4、Sox2和SV40T的mRNA体外转录载体,并对体外转录mRNA进行了5′和3′端加工修饰;进行了诱导因子mRNA的293和IMR90细胞转染试验,利用免疫细胞化学、免疫荧光和Real-Time PCR分别检测了Oct4、Sox2、SV40T和Nanog的表达情况。结果显示,以上2种细胞以Oct4∶Sox2∶SV40T=2∶1∶1的mRNA比例转染后均表达这3种特定诱导因子,且相应蛋白都正确地定位在细胞核上。转染细胞中Oct4和Nanog的表达都特异性地增高。结果提示,3种诱导因子的体外转录mRNA能够在体内协同作用,激活细胞内源性干性标志基因Nanog的表达,为开启重编程过程奠定了坚实的基础。 The aim of this study was to reprogram fibroblasts cell by in vitro transcribed mRNA cocktail of Oct4, Sox2 and SV40 T-antigen, and provide a safe, nonintegrating strategy for somatic cell reprogramming. The reeombinated mRNA transcription vectors including the above three induced facotrs genes were constructed and transcripted, respectively, then 5IUTR and 3I UTR of β-globin gene were used for stabilizing in vitro transcribed mRNA following in vitro cap- ping and poly(A) tailing. After mRNA transfection of 293 and IMRg0 cells, immunocytochemistry, immunoflurescence and Real-Time PCR methods were used to detect gene expression, pro- tein location and endogenous gene expression related to pluripotence. The results showed that target gene expressions could be detected in 293 and IMR90 cells and all expressed protein were localized properly in the nucleus. The specific expression of Oct4 and Nanog were increased in transfection cells. Endogenous Nanog expression was induced by mRNA cock-tail transfection. These findings indicate that mRNA of Oct4, Sox2 and SV40 T in vitro can coorperate to initiate cellular reprogramming.
出处 《畜牧兽医学报》 CAS CSCD 北大核心 2012年第11期1733-1739,共7页 ACTA VETERINARIA ET ZOOTECHNICA SINICA
基金 国家自然科学基金(31000655) 西北农林科技大学博士启动基金(2010BSJJ049) NIH项目(R21RR025408)
关键词 特定诱导因子 MRNA 重编程 诱导多潜能干细胞(iPS) specific induced factor mRNA reprogramming induced pluripotent stem cell (iPS)
  • 相关文献

参考文献1

二级参考文献19

  • 1Richards, M., Tan, S., Fong, C.Y., Biswas, A., Chan, W.K., and Bongso, A. (2003). Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells Stem Cells 21 : 546-556.
  • 2Saxena, S., Hanwate, M., Deb, K., Sharma, V., and Totey, S. (2008). FGF2 secreting human fibroblast feeder cells: a novel culture system for human embryonic stem cells. Mol. Reprod. Dev. 75: 1523-1532.
  • 3Simon, C., Escohedo, C., Valbuena, D., Genhacev, O., Galan, A., Krtolica, A., Asensi, A., Sanchez, E., Esplugues, J., Fisher, S., and Pellieer, A. (2005). First derivation in Spain of human embryonic stem cell lines: use of long-term cryopreserved embryos and animal-free conditions. Fertil. Steril. 83: 246-249.
  • 4Stojkovic, P., Lako, M., Stewart, R., Przyborski, S., Armstrong, L., Evans, J., Murdoch, A., Strachan, T., and Stojkovic, M. (2005). An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 23:306-314.
  • 5Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
  • 6Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
  • 7Thomson, J.A., Itskovitz-Eldor, J, Shapiro, S.S, Waknitz, M.A, Swiergiel, J.J., Marshall, V.S, and Jones, J.M. (1998). Embryonic stern cell lines derived from human blastocysts. Science 282:1145-1147.
  • 8Unger, C., Skottman, H., Blomberg, P., DUber, M.S., and Hovatta, O. (2008). Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17: R48-R53.
  • 9Xu, C., Jiang, J., Sottile, V., McWhir, J., Lebkowski, J., and Carpenter, M.K. (2004). Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22: 972-980.
  • 10Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Franc, J.L., Tian, S., Nic, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, Ⅱ, and Thomson, J.A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.

共引文献4

同被引文献56

  • 1Nilsen T W,Maroney P A.Translational efficiency of cMyc mRNA in Burkitt lymphoma cells[J].Mol Cell Biol,1984,4(10):2 235-2 238.
  • 2Shortt J,Martin B P,Newbold A,et al.Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas[J].Blood,2013,121(15):2 964-2 974.
  • 3Rezanejad H,Matin M M.Induced pluripotent stem cells:progress and future perspectives in the stem cell world[J].Cell Reprogram,2012,14(6):459-470.
  • 4Bellin M,Marchetto M C,Gage F H,et al.Induced pluripotent stem cells:the new patient[J].Nat Rev Mol Cell Biol,2012,13(11):713-726.
  • 5Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J].Cell,2006,126(4):663-676.
  • 6Mandal P K,Rossi D J.Reprogramming human fibroblasts to pluripotency using modified mRNA[J].Nat Protoc,2013,8(3):568-582.
  • 7Pan C,Lan X,Chen H,et al.An economical single-sided antibody incubation method for western blotting[J].J Virol Methods,2010,169:409-411.
  • 8Regberg J,Eriksson J N,Langel U.Cell-penetrating peptides:from cell cultures to in vivo applications[J].Front Biosci(Elite Ed),2013,5:509-516.
  • 9Zhou H,Wu S,Joo J Y,et al.Generation of induced pluripotent stem cells using recombinant proteins[J].Cell Stem Cell,2009,4(5):381-384.
  • 10Kim D,Kim C H,Moon J I,et al.Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins[J].Cell Stem Cell,2009,4(6):472-476.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部